Silicon Laboratories (NASDAQ:SLAB) SVP Brandon Tolany Sells 8,000 Shares

Key Points

• Brandon Tolany, SVP of Silicon Laboratories, sold 8,000 shares for approximately $1.16 million, reducing his stake by 11.38% to 62,328 shares.
• The stock price of Silicon Laboratories decreased by 2.0%, trading at $142.22, with a market capitalization of $4.67 billion.
• The company reported a 32.6% increase in revenue year-over-year, achieving $192.85 million in the latest quarter.

Silicon Laboratories, Inc. (NASDAQ:SLAB - Get Free Report) SVP Brandon Tolany sold 8,000 shares of the firm's stock in a transaction that occurred on Friday, August 22nd. The stock was sold at an average price of $145.23, for a total transaction of $1,161,840.00. Following the sale, the senior vice president owned 62,328 shares of the company's stock, valued at $9,051,895.44. This trade represents a 11.38% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.

Brandon Tolany also recently made the following trade(s):

• On Tuesday, August 19th, Brandon Tolany sold 2,270 shares of Silicon Laboratories stock. The stock was sold at an average price of $132.69, for a total transaction of $301,206.30.

Silicon Laboratories Trading Down 2.0%

SLAB stock traded down $2.90 during mid-day trading on Monday, hitting $142.22. 244,532 shares of the company were exchanged, compared to its average volume of 391,833. The business has a 50 day simple moving average of $139.10 and a 200-day simple moving average of $127.65. The stock has a market capitalization of $4.67 billion, a PE ratio of -44.17 and a beta of 1.48. Silicon Laboratories, Inc. has a 1-year low of $82.82 and a 1-year high of $160.00.

Silicon Laboratories (NASDAQ:SLAB - Get Free Report) last issued its quarterly earnings data on Tuesday, August 5th. The semiconductor company reported $0.11 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.09 by $0.02. The firm had revenue of $192.85 million during the quarter, compared to the consensus estimate of $192.57 million. Silicon Laboratories had a negative net margin of 14.88% and a negative return on equity of 7.21%. The business's revenue for the quarter was up 32.6% compared to the same quarter last year. During the same period last year, the business posted ($0.56) earnings per share. Silicon Laboratories has set its Q3 2025 guidance at 0.200-0.400 EPS. Equities research analysts expect that Silicon Laboratories, Inc. will post -0.97 earnings per share for the current year.

Analysts Set New Price Targets

A number of equities research analysts have recently weighed in on the stock. KeyCorp lifted their price target on shares of Silicon Laboratories from $160.00 to $180.00 and gave the company an "overweight" rating in a research report on Tuesday, July 8th. Benchmark reiterated a "buy" rating and issued a $160.00 price target on shares of Silicon Laboratories in a research report on Tuesday, May 27th. Wall Street Zen upgraded shares of Silicon Laboratories from a "sell" rating to a "hold" rating in a research report on Wednesday, May 14th. Stifel Nicolaus lifted their price target on shares of Silicon Laboratories from $144.00 to $160.00 and gave the company a "buy" rating in a research report on Friday, July 18th. Finally, Susquehanna lifted their price target on shares of Silicon Laboratories from $110.00 to $150.00 and gave the company a "neutral" rating in a research report on Tuesday, July 22nd. Five analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average target price of $151.13.

Hedge Funds Weigh In On Silicon Laboratories

Hedge funds have recently modified their holdings of the company. Quarry LP purchased a new position in Silicon Laboratories in the 1st quarter valued at approximately $25,000. Skandinaviska Enskilda Banken AB publ purchased a new stake in Silicon Laboratories during the first quarter valued at about $34,000. UMB Bank n.a. boosted its position in Silicon Laboratories by 111.3% during the first quarter. UMB Bank n.a. now owns 336 shares of the semiconductor company's stock valued at $38,000 after buying an additional 177 shares during the period. Parallel Advisors LLC boosted its position in Silicon Laboratories by 143.7% during the first quarter. Parallel Advisors LLC now owns 463 shares of the semiconductor company's stock valued at $52,000 after buying an additional 273 shares during the period. Finally, Larson Financial Group LLC purchased a new stake in Silicon Laboratories during the first quarter valued at about $55,000.

About Silicon Laboratories

Silicon Laboratories Inc, a fabless semiconductor company, provides various analog-intensive mixed-signal solutions in the United States, China, Taiwan, and internationally. The company's products include wireless microcontrollers and sensor products. Its products are used in various electronic products in a range of applications for the industrial Internet of Things (IoT), including industrial automation and control, smart buildings, access control, HVAC control, and industrial wearables and power tools; smart cities applications, such as smart metering, smart street lighting, renewable energy, electric vehicle supply equipment, and smart agriculture; commercial IoT applications, including smart lighting, asset tracking, electronic shelf labels, theft protection, and enterprise access points; smart home applications, comprising home automation/security systems, smart speakers, smart lighting, HVAC control, smart cameras, smart appliances, smart home sensing, smart locks, and window/blind controls; and connected health applications, including diabetes management, consumer health and fitness, elderly care, patient monitoring, and activity tracking; as well as in commercial building automation, consumer electronics, and medical instrumentation.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.